Education
About Us
Working with TipRanks
Follow Us
Eloxx Pharmaceuticals Inc (ELOX)
OTHER OTC:ELOX
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -34.42M | $ -66.02M | $ -33.45M | $ -50.55M | $ -47.56M |
| EBITDA | $ -31.75M | $ -64.51M | $ -32.60M | $ -48.70M | $ -46.15M |
| Net Income | $ -36.06M | $ -66.73M | $ -34.58M | $ -50.87M | $ -47.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 19.21M | $ 42.27M | $ 24.67M | $ 56.28M | $ 48.61M |
| Total Assets | $ 21.12M | $ 45.14M | $ 26.48M | $ 58.95M | $ 50.72M |
| Total Debt | $ 13.38M | $ 13.46M | $ 12.04M | $ 15.76M | $ 0.00 |
| Net Debt | $ -5.82M | $ -28.81M | $ -12.63M | $ -6.73M | $ -48.61M |
| Total Liabilities | $ 31.78M | $ 22.75M | $ 16.25M | $ 22.73M | $ 7.81M |
| Stockholders' Equity | $ -10.66M | $ 22.38M | $ 10.23M | $ 36.21M | $ 42.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -31.91M | $ -35.09M | $ -28.17M | $ -39.43M | $ -31.60M |
| Operating Cash Flow | $ -31.84M | $ -35.00M | $ -28.17M | $ -39.39M | $ -31.37M |
| Investing Cash Flow | $ -66.00K | $ 2.06M | $ 33.79M | $ -33.52M | $ -317.00K |
| Financing Cash Flow | $ 8.81M | $ 50.79M | $ -3.44M | $ 46.80M | $ 56.18M |
Eloxx Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.